A Significant Achievement for our Research Group

We are proud to announce that our project has been awarded 4th place in the prestigious FINEP Mais Inovação Saúde grant! This funding of 8 million reais marks a significant step forward in our preclinical and clinical research, focusing on developing monoclonal antibodies and siRNA therapies for oncology in the public health system (SUS).

Our commitment is to transform the landscape of public health by offering innovative solutions that directly benefit the population. Securing this grant not only validates the excellence of our proposal but also reinforces our mission to contribute to science and society.

We extend our heartfelt thanks to everyone involved in this ambitious project and remain dedicated to making a difference in the lives of thousands of people. Together, we are pushing the boundaries of knowledge and cutting-edge therapies.